Hering S - Search Results

1

Radiotherapy enhances uptake and efficacy of ⁹⁰Y-cetuximab: A preclinical trial.

Dietrich A, Andreeff M, Koi L, Bergmann R, Schubert M, Schreiner L, Löck S, Sihver W, Freudenberg R, Hering S, Pietzsch HJ, Steinbach J, Kotzerke J, Baumann M, Krause M. Dietrich A, et al. Among authors: hering s. Radiother Oncol. 2021 Feb;155:285-292. doi: 10.1016/j.radonc.2020.11.013. Epub 2020 Nov 21. Radiother Oncol. 2021. PMID: 33227356 Free article.

2

EGFR-amplification plus gene expression profiling predicts response to combined radiotherapy with EGFR-inhibition: A preclinical trial in 10 HNSCC-tumour-xenograft models.

Koi L, Löck S, Linge A, Thurow C, Hering S, Baumann M, Krause M, Gurtner K. Koi L, et al. Among authors: hering s. Radiother Oncol. 2017 Sep;124(3):496-503. doi: 10.1016/j.radonc.2017.07.009. Epub 2017 Aug 11. Radiother Oncol. 2017. PMID: 28807520

3

Residual gammaH2AX foci in head and neck squamous cell carcinomas as predictors for tumour radiosensitivity: Evaluation in pre-clinical xenograft models and clinical specimens.

Meneceur S, Löck S, Gudziol V, Hering S, Bütof R, Rehm M, Baumann M, Krause M, von Neubeck C. Meneceur S, et al. Among authors: hering s. Radiother Oncol. 2019 Aug;137:24-31. doi: 10.1016/j.radonc.2019.04.009. Epub 2019 Apr 29. Radiother Oncol. 2019. PMID: 31048234

4

In reply to the Letter to the Editor by Chen and Lui regarding "Radiotherapy enhances uptake and efficacy of ⁹⁰Y-cetuximab: A preclinical trial" by A Dietrich et al.

Dietrich A, Andreeff M, Koi L, Bergmann R, Schubert M, Schreiner L, Löck S, Sihver W, Freudenberg R, Hering S, Pietzsch HJ, Steinbach J, Kotzerke J, Baumann M, Krause M. Dietrich A, et al. Among authors: hering s. Radiother Oncol. 2021 Aug;161:261-262. doi: 10.1016/j.radonc.2021.06.014. Epub 2021 Jun 11. Radiother Oncol. 2021. PMID: 34119587 No abstract available.

5

Combination of EGFR/HER2 tyrosine kinase inhibition by BIBW 2992 and BIBW 2669 with irradiation in FaDu human squamous cell carcinoma.

Schütze C, Dörfler A, Eicheler W, Zips D, Hering S, Solca F, Baumann M, Krause M. Schütze C, et al. Among authors: hering s. Strahlenther Onkol. 2007 May;183(5):256-64. doi: 10.1007/s00066-007-1696-z. Strahlenther Onkol. 2007. PMID: 17497097

6

CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell lines HCT-116.

Dittfeld C, Dietrich A, Peickert S, Hering S, Baumann M, Grade M, Ried T, Kunz-Schughart LA. Dittfeld C, et al. Among authors: hering s. Radiother Oncol. 2009 Sep;92(3):353-61. doi: 10.1016/j.radonc.2009.06.034. Epub 2009 Aug 21. Radiother Oncol. 2009. PMID: 19699546

7

CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell line HCT-116.

Dittfeld C, Dietrich A, Peickert S, Hering S, Baumann M, Grade M, Ried T, Kunz-Schughart LA. Dittfeld C, et al. Among authors: hering s. Radiother Oncol. 2010 Mar;94(3):375-83. doi: 10.1016/j.radonc.2009.10.010. Radiother Oncol. 2010. PMID: 20344822 Free PMC article.

8

Radiobiological hypoxia, histological parameters of tumour microenvironment and local tumour control after fractionated irradiation.

Yaromina A, Thames H, Zhou X, Hering S, Eicheler W, Dörfler A, Leichtner T, Zips D, Baumann M. Yaromina A, et al. Among authors: hering s. Radiother Oncol. 2010 Jul;96(1):116-22. doi: 10.1016/j.radonc.2010.04.020. Radiother Oncol. 2010. PMID: 20570380

9

γH2AX assay in ex vivo irradiated tumour specimens: A novel method to determine tumour radiation sensitivity in patient-derived material.

Menegakis A, von Neubeck C, Yaromina A, Thames H, Hering S, Hennenlotter J, Scharpf M, Noell S, Krause M, Zips D, Baumann M. Menegakis A, et al. Among authors: hering s. Radiother Oncol. 2015 Sep;116(3):473-9. doi: 10.1016/j.radonc.2015.03.026. Epub 2015 Apr 9. Radiother Oncol. 2015. PMID: 25866027

10

Radioresistance of KRAS/TP53-mutated lung cancer can be overcome by radiation dose escalation or EGFR tyrosine kinase inhibition in vivo.

Gurtner K, Kryzmien Z, Koi L, Wang M, Benes CH, Hering S, Willers H, Baumann M, Krause M. Gurtner K, et al. Among authors: hering s. Int J Cancer. 2020 Jul 15;147(2):472-477. doi: 10.1002/ijc.32598. Epub 2019 Aug 19. Int J Cancer. 2020. PMID: 31359406 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

337 results

Search Page

Filters